Zeta-BC-003

N/A

Report date: 2024/12/25 18:00:42
NME

Base Information

Drug NameZeta-BC-003
Drug Alias NameZetaMetZetaFuseZeta-BC-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerNervous System DiseasesIntervertebral Disc Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaAustralia
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesZetagen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZetagen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerNervous System DiseasesIntervertebral Disc Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A